Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.

Authors: Koeners, Maarten P; Wesseling, Sebastiaan; Ulu, Arzu; Sepulveda, Rocio Lopez; Morisseau, Christophe; Braam, Branko; Hammock, Bruce D; Joles, Jaap A

Published In Am J Physiol Endocrinol Metab, (2011 Apr)

Abstract: We hypothesized that perinatal inhibition of soluble epoxide hydrolase (SEH), which metabolizes epoxyeicosatrienoic acids in the arachidonic acid (AA) cascade, with an orally active SEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA), would persistently reduce blood pressure (BP) in adult SHR despite discontinuation of AUDA at 4 wk of age. Renal cytoplasmic epoxide hydrolase-2 (Ephx2) gene expression was enhanced in SHR vs. WKY from 2 days to 24 wk. Effects of perinatal treatment with AUDA, supplied to SHR dams until 4 wk after birth, on BP in female and male offspring and renal oxylipin metabolome in female offspring were observed and contrasted to female SHR for direct effects of AUDA (8-12 wk). Briefly, inhibition of SEH was effective in persistently reducing BP in female SHR when applied during the perinatal phase. This was accompanied by marked increases in major renal AA epoxides and decreases in renal lipoxygenase products of AA. Early inhibition of SEH induced a delayed increase in renal 5-HETE at 24 wk, in contrast to a decrease at 2 wk. Inhibition of SEH in female SHR from 8 to 12 wk did not reduce BP but caused profound decreases in renal 15(S)-HETrE, LTB4, TBX2, 5-HETE, and 20-HETE and increases in TriHOMEs. In male SHR, BP reduction after perinatal AUDA was transient. Thus, Ephx2 transcription and SEH activity in early life may initiate mechanisms that eventually contribute to high BP in adult female SHR. However, programmed BP-lowering effects of perinatal SEH inhibition in female SHR cannot be simply explained by persistent reduction in renal SEH activity but rather by more complex and temporally dynamic interactions between the renal SEH, lipoxygenase, and cyclooxygenase pathways.

PubMed ID: 21266668 Exiting the NIEHS site

MeSH Terms: Adamantane/analogs & derivatives*; Age Factors; Animals; Enzyme Inhibitors; Epoxide Hydrolases/antagonists & inhibitors*; Epoxide Hydrolases/genetics; Epoxide Hydrolases/metabolism; Epoxide Hydrolases/physiology*; Female; Gestational Age; Hypertension/chemically induced*; Hypertension/pathology; Hypertension/physiopathology*; Lauric Acids*; Male; Pregnancy; Prenatal Exposure Delayed Effects/chemically induced; Prenatal Exposure Delayed Effects/pathology; Prenatal Exposure Delayed Effects/physiopathology; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction/drug effects; Signal Transduction/genetics; Signal Transduction/physiology; Solubility

Back
to Top